94 related articles for article (PubMed ID: 24561267)
1. Galectin-3 binds to MUC1-N-terminal domain and triggers recruitment of β-catenin in MUC1-expressing mouse 3T3 cells.
Tanida S; Mori Y; Ishida A; Akita K; Nakada H
Biochim Biophys Acta; 2014 Jun; 1840(6):1790-7. PubMed ID: 24561267
[TBL] [Abstract][Full Text] [Related]
2. Binding of the sialic acid-binding lectin, Siglec-9, to the membrane mucin, MUC1, induces recruitment of β-catenin and subsequent cell growth.
Tanida S; Akita K; Ishida A; Mori Y; Toda M; Inoue M; Ohta M; Yashiro M; Sawada T; Hirakawa K; Nakada H
J Biol Chem; 2013 Nov; 288(44):31842-52. PubMed ID: 24045940
[TBL] [Abstract][Full Text] [Related]
3. Binding of Galectin-3, a β-Galactoside-binding Lectin, to MUC1 Protein Enhances Phosphorylation of Extracellular Signal-regulated Kinase 1/2 (ERK1/2) and Akt, Promoting Tumor Cell Malignancy.
Mori Y; Akita K; Yashiro M; Sawada T; Hirakawa K; Murata T; Nakada H
J Biol Chem; 2015 Oct; 290(43):26125-40. PubMed ID: 26342075
[TBL] [Abstract][Full Text] [Related]
4. The MUC1 and galectin-3 oncoproteins function in a microRNA-dependent regulatory loop.
Ramasamy S; Duraisamy S; Barbashov S; Kawano T; Kharbanda S; Kufe D
Mol Cell; 2007 Sep; 27(6):992-1004. PubMed ID: 17889671
[TBL] [Abstract][Full Text] [Related]
5. Interaction of human MUC1 and beta-catenin is regulated by Lck and ZAP-70 in activated Jurkat T cells.
Li Q; Ren J; Kufe D
Biochem Biophys Res Commun; 2004 Mar; 315(2):471-6. PubMed ID: 14766232
[TBL] [Abstract][Full Text] [Related]
6. MUC1 alters beta-catenin-dependent tumor formation and promotes cellular invasion.
Schroeder JA; Adriance MC; Thompson MC; Camenisch TD; Gendler SJ
Oncogene; 2003 Mar; 22(9):1324-32. PubMed ID: 12618757
[TBL] [Abstract][Full Text] [Related]
7. Endogenous and exogenous galectin-3 promote the adhesion of tumor cells with low expression of MUC1 to HUVECs through upregulation of N-cadherin and CD44.
Cao Z; Hao Z; Xin M; Yu L; Wang L; Zhang Y; Zhang X; Guo X
Lab Invest; 2018 Dec; 98(12):1642-1656. PubMed ID: 30171204
[TBL] [Abstract][Full Text] [Related]
8. Interference of mucin 1 inhibits progression of colon carcinoma by repression of Wnt/β-catenin signaling.
Wang Z; Sun J; Hu X; Huang S
DNA Cell Biol; 2014 Mar; 33(3):162-70. PubMed ID: 24410135
[TBL] [Abstract][Full Text] [Related]
9. Intracellular MUC1 peptides inhibit cancer progression.
Bitler BG; Menzl I; Huerta CL; Sands B; Knowlton W; Chang A; Schroeder JA
Clin Cancer Res; 2009 Jan; 15(1):100-9. PubMed ID: 19118037
[TBL] [Abstract][Full Text] [Related]
10. MUC1 oncoprotein blocks glycogen synthase kinase 3beta-mediated phosphorylation and degradation of beta-catenin.
Huang L; Chen D; Liu D; Yin L; Kharbanda S; Kufe D
Cancer Res; 2005 Nov; 65(22):10413-22. PubMed ID: 16288032
[TBL] [Abstract][Full Text] [Related]
11. Interaction of galectin-3 with MUC1 on cell surface promotes EGFR dimerization and activation in human epithelial cancer cells.
Piyush T; Chacko AR; Sindrewicz P; Hilkens J; Rhodes JM; Yu LG
Cell Death Differ; 2017 Nov; 24(11):1937-1947. PubMed ID: 28731466
[TBL] [Abstract][Full Text] [Related]
12. Activation of the Wnt/beta-catenin signaling pathway during oral carcinogenesis process is not influenced by the absence of galectin-3 in mice.
Sant'ana JM; Chammas R; Liu FT; Nonogaki S; Cardoso SV; Loyola AM; de Faria PR
Anticancer Res; 2011 Sep; 31(9):2805-11. PubMed ID: 21868523
[TBL] [Abstract][Full Text] [Related]
13. MUC1 inhibits cell proliferation by a beta-catenin-dependent mechanism.
Lillehoj EP; Lu W; Kiser T; Goldblum SE; Kim KC
Biochim Biophys Acta; 2007 Jul; 1773(7):1028-38. PubMed ID: 17524503
[TBL] [Abstract][Full Text] [Related]
14. The cytoplasmic domain of MUC1 induces hyperplasia in the mammary gland and correlates with nuclear accumulation of β-catenin.
Li Y; Yi H; Yao Y; Liao X; Xie Y; Yang J; Yan Z; Wang L; Lu S; Kuang Y; Gu M; Fei J; Wang Z; Huang L
PLoS One; 2011 Apr; 6(4):e19102. PubMed ID: 21533058
[TBL] [Abstract][Full Text] [Related]
15. Thermodynamic Switch in Binding of Adhesion/Growth Regulatory Human Galectin-3 to Tumor-Associated TF Antigen (CD176) and MUC1 Glycopeptides.
Rodriguez MC; Yegorova S; Pitteloud JP; Chavaroche AE; André S; Ardá A; Minond D; Jiménez-Barbero J; Gabius HJ; Cudic M
Biochemistry; 2015 Jul; 54(29):4462-74. PubMed ID: 26129647
[TBL] [Abstract][Full Text] [Related]
16. Induction of Trop-2 expression through the binding of galectin-3 to MUC1.
Yamashita T; Mori Y; Alzaaqi SM; Yashiro M; Sawada T; Hirakawa K; Nakada H
Biochem Biophys Res Commun; 2019 Aug; 516(1):44-49. PubMed ID: 31196625
[TBL] [Abstract][Full Text] [Related]
17. Interaction of MUC1 with beta-catenin modulates the Wnt target gene cyclinD1 in H. pylori-induced gastric cancer.
Udhayakumar G; Jayanthi V; Devaraj N; Devaraj H
Mol Carcinog; 2007 Sep; 46(9):807-17. PubMed ID: 17393422
[TBL] [Abstract][Full Text] [Related]
18. Sialylation regulates galectin-3/ligand interplay during mammary tumour progression--a case of targeted uncloaking.
de Oliveira JT; de Matos AJ; Santos AL; Pinto R; Gomes J; Hespanhol V; Chammas R; Manninen A; Bernardes ES; Albuquerque Reis C; Rutteman G; Gärtner F
Int J Dev Biol; 2011; 55(7-9):823-34. PubMed ID: 22161838
[TBL] [Abstract][Full Text] [Related]
19. MUC1 drives epithelial-mesenchymal transition in renal carcinoma through Wnt/β-catenin pathway and interaction with SNAIL promoter.
Gnemmi V; Bouillez A; Gaudelot K; Hémon B; Ringot B; Pottier N; Glowacki F; Villers A; Vindrieux D; Cauffiez C; Van Seuningen I; Bernard D; Leroy X; Aubert S; Perrais M
Cancer Lett; 2014 May; 346(2):225-36. PubMed ID: 24384091
[TBL] [Abstract][Full Text] [Related]
20. Expression of KL-6/MUC1 in pancreatic cancer tissues and its potential involvement in tumor metastasis.
Xu H; Inagaki Y; Seyama Y; Du G; Wang F; Kokudo N; Tang W
Oncol Rep; 2011 Aug; 26(2):371-6. PubMed ID: 21617869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
